These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 18472355

  • 1. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T, Terhaard CH, Roesink JM, Braam PM, van Gils CH, Moerland MA, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1101-9. PubMed ID: 18472355
    [Abstract] [Full Text] [Related]

  • 2. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Okumura M, Suzuki M.
    Jpn J Clin Oncol; 2005 Jul 15; 35(7):375-9. PubMed ID: 15976068
    [Abstract] [Full Text] [Related]

  • 3. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy.
    Braam PM, Terhaard CH, Roesink JM, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):975-80. PubMed ID: 16965864
    [Abstract] [Full Text] [Related]

  • 4. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
    Houweling AC, Philippens ME, Dijkema T, Roesink JM, Terhaard CH, Schilstra C, Ten Haken RK, Eisbruch A, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1259-65. PubMed ID: 20005639
    [Abstract] [Full Text] [Related]

  • 5. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

  • 6. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):663-73. PubMed ID: 14967418
    [Abstract] [Full Text] [Related]

  • 7. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S, Iaccarino G, Pasciuti K, Soriani A, Benassi M, Arcangeli G, Giovinazzo G, Benassi M, Marucci L.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1252-9. PubMed ID: 19251097
    [Abstract] [Full Text] [Related]

  • 8. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Kirwan J, Mendenhall WM.
    Laryngoscope; 2009 Oct 15; 119(10):1966-74. PubMed ID: 19688858
    [Abstract] [Full Text] [Related]

  • 9. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):1-8. PubMed ID: 19111400
    [Abstract] [Full Text] [Related]

  • 10. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
    Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1475-80. PubMed ID: 19515505
    [Abstract] [Full Text] [Related]

  • 11. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA, Stavrev P, Parliament MB, Field C, Thompson H, Stavreva N, Fallone BG.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):178-85. PubMed ID: 15337554
    [Abstract] [Full Text] [Related]

  • 12. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den Bogaert W.
    Radiother Oncol; 2004 Aug 01; 72(2):119-27. PubMed ID: 15297131
    [Abstract] [Full Text] [Related]

  • 13. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):981-91. PubMed ID: 17145528
    [Abstract] [Full Text] [Related]

  • 14. Long-term parotid gland function after radiotherapy.
    Braam PM, Roesink JM, Moerland MA, Raaijmakers CP, Schipper M, Terhaard CH.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):659-64. PubMed ID: 15936542
    [Abstract] [Full Text] [Related]

  • 15. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M.
    Radiother Oncol; 2006 Mar 01; 78(3):270-5. PubMed ID: 16564589
    [Abstract] [Full Text] [Related]

  • 16. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.
    Johansson J, Blomquist E, Montelius A, Isacsson U, Glimelius B.
    Radiother Oncol; 2004 Aug 01; 72(2):129-38. PubMed ID: 15297132
    [Abstract] [Full Text] [Related]

  • 17. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, Teknos TN, Anzai Y, Marsh LH, Martel MK, Ten Haken RK, Wolf GT, Ship JA.
    Acta Otorhinolaryngol Belg; 1999 Aug 01; 53(3):271-5. PubMed ID: 10635407
    [Abstract] [Full Text] [Related]

  • 18. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
    Ortholan C, Chamorey E, Benezery K, Thariat J, Dassonville O, Poissonnet G, Bozec A, Follana P, Peyrade F, Sudaka A, Gerard JP, Bensadoun RJ.
    Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):178-86. PubMed ID: 18565687
    [Abstract] [Full Text] [Related]

  • 19. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA, Li XA.
    Phys Med Biol; 2008 Feb 07; 53(3):737-55. PubMed ID: 18199912
    [Abstract] [Full Text] [Related]

  • 20. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T, Jirsak N, Müller AC, Pelz T, Gernhardt C, Schaller HG, Janich M, Gerlach R, Dunst J.
    Strahlenther Onkol; 2005 Aug 07; 181(8):520-8. PubMed ID: 16044220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.